跳至主要内容
临床试验/NCT06529341
NCT06529341尚未招募不适用

Efficacy of High-precision Transcranial Direct Current Stimulation on Anxiety Disorders

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年7月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Hamilton Anxiety Scale

研究概览

简要总结

  1. Current research has found that tDCS has a positive effect on improving the negative attention bias of AD patients, and this study uses HD-tDCS intervention to improve the cognitive function and neural mechanisms of AD patients in the OFC to provide a theoretical basis for AD neural mechanism research. Verify Hypothesis 1: HD-tDCS cathodal stimulation of the left OFC reduces the excitability of this region, modulates its connectivity with the attentional function network, and thus changes the emotional experience of social threat.
  2. Currently, there is no consensus on the stimulation parameters for tDCS in the treatment of AD, and more evidence is needed to prove and explore. It is hoped that the HD-tDCS intervention protocol will become an effective treatment method for improving cognitive function and clinical symptoms in AD patients. Hypothesis 2: The HD-tDCS with intensified stimulation parameters (2mA, twice a day, with a 20-minute interval, for 5 consecutive days) has an impact on the main and secondary clinical variables of AD patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Meet the DSM-5 AD diagnostic criteria;
  • •The Chinese version of the Brief International Neuropsychiatric Interview (MINI) screening meets the diagnosis;
  • •Age: 18-55 years old;
  • •The patient participated voluntarily, obtained the consent of the family members, and signed the informed consent form;
  • •Scale score criteria: 14 points on the Hamilton Anxiety Scale (HAMA) and 17 points on the Hamilton Depression Scale (HAMD).

排除标准

  • •Neurological diseases or other psychiatric disorders;
  • •severe somatic diseases;
  • •received medical treatment including medication, psychotherapy, electroconvulsive therapy, and physical therapy within the first half months of enrollment;
  • •tDCS examination contraindications, such as intracranial metal or electronic implants, skull plate, or other skull implants.
  • •Pregnancy and lactation.

研究组 & 干预措施

High-definition transcranial direct current stimulation

Experimental

HD-tDCS stimulated AD left OFC (2 mA, 20 minutes, cathode electrode placed in the Fp 1 area, and the remaining four positive electrodes placed AF3, AF7, Afz, Fpz, forming a circular 41 focused electric field mode for stimulation, twice a day, 20 minutes interval for 5 days)

干预措施: High-definition transcranial direct current stimulation (Other)

High-definition transcranial direct current stimulation pseudo-stimulation control group

Active Comparator

The treatment parameters of the electrode were the same as the test group, the stimulation current rose to the same 2 mA current in the test group within 30 seconds, and the pre-stimulation for 1 minute, then gradually to 0 mA.

干预措施: High-definition transcranial direct current stimulation pseudo-stimulation control group (Other)

结局指标

主要结局

Hamilton Anxiety Scale

时间窗: 1 week

HAMA was assessed at baseline and late 5 days after treatment by a professionally trained physician (non-trial intervention) to understand the effectiveness of treatment. Clinical efficacy evaluation criteria: 75% was recovered, 50% was significant, 25% was effective, and \<25% was invalid.

次要结局

未报告次要终点

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chun Wang

professor

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验